CARD16 and Sjogren syndrome: Anti-Ro52 reactivity was high in ASS (83.9%) and Sjogren’s syndrome (92.3%, S3 Table in S1 File) but also observed in unclassifiable IIP, NSIP and COP (range 27.3–54.8%; S4 Table in S1 File).